G.L. Buraggi
Impact in
-
- Monoclonal and Polyclonal Antibodies Research
- Radiopharmaceutical Chemistry and Applications
- Oncology top 10%
- HER2/EGFR in Cancer Research
- Peptidase Inhibition and Analysis
Papers in
-
- Monoclonal and Polyclonal Antibodies Research 26
- Radiopharmaceutical Chemistry and Applications 24
- Medical Imaging Techniques and Applications 4
-
- Medical Imaging and Pathology Studies 8
- Co-authors
- Emilio Bombardieri (16 shared papers)L. Callegaro (10 shared papers)Ettore Seregni (13 shared papers)Giuliano Mariani (5 shared papers)Flavio Crippa (5 shared papers)Massimo Gasparini (10 shared papers)M. Dovis (3 shared papers)Marco Gasparini (7 shared papers)
- Journals
- The International Journal of Biological Markers (8 papers)European Journal of Cancer (4 papers)Cancer (2 papers)Cancer treatment and research (1 paper)International Journal of Cancer (1 paper)
- Partner nations
- ItalyUnited StatesGermany
In The Last Decade
G.L. Buraggi
47 papers receiving 834 citations
Peers
Comparison fields: 5 of 52
- Radiology, Nuclear Medicine and Imaging 615
- Oncology 312
- Immunology and Allergy 41
- Pathology and Forensic Medicine 114
- Immunology 113
Countries citing papers authored by G.L. Buraggi
This map shows the geographic impact of G.L. Buraggi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G.L. Buraggi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G.L. Buraggi more than expected).
Fields of papers citing papers by G.L. Buraggi
This network shows the impact of papers produced by G.L. Buraggi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G.L. Buraggi. The network helps show where G.L. Buraggi may publish in the future.
Co-authors
The 25 scholars most cited alongside G.L. Buraggi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 48 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Multicenter study of immunoscintigraphy with radiolabeled monoclonal antibodies in patients with melanoma. | 1986 | 134 |
| 2 | Imaging with 131I-labeled monoclonal antibodies to a high-molecular-weight melanoma-associated antigen in patients with melanoma: efficacy of whole immunoglobulin and its F(ab')2 fragments. | 1985 | 129 |
| 3 | 1995 | 75 | |
| 4 | Immunoscintigraphy of adenocarcinomas by means of radiolabeled F(ab')2 fragments of an anti-carcinoembryonic antigen monoclonal antibody: a multicenter study. | 1989 | 67 |
| 5 | 1991 | 60 | |
| 6 | 1995 | 42 | |
| 7 | Immunoscintigraphy of colorectal carcinoma with F (ab')2 fragments of anti-CEA monoclonal antibody. | 1987 | 40 |
| 8 | 1989 | 38 | |
| 9 | Scintigraphic detection of melanoma metastases with a radiolabeled benzamide ([iodine-123]-(S)-IBZM). | 1994 | 32 |
| 10 | Bone scintigraphy in breast cancer: a ten-year follow-up study. | 1993 | 20 |
| 11 | 1986 | 17 | |
| 12 | 1988 | 17 | |
| 13 | 1989 | 16 | |
| 14 | 1998 | 15 | |
| 15 | 1994 | 15 | |
| 16 | 1965 | 15 | |
| 17 | 1993 | 15 | |
| 18 | 1981 | 13 | |
| 19 | Improved staging of B-cell non-Hodgkin's lymphoma patients with 99mTc-labeled LL2 monoclonal antibody fragment. | 1995 | 12 |
| 20 | Markers for Diagnosis and Monitoring of Human Cancer | 1982 | 12 |
About G.L. Buraggi
G.L. Buraggi is a scholar working on Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine, Molecular Biology, Oncology and Immunology, having authored 48 papers that have together received 908 indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (26 papers), Radiopharmaceutical Chemistry and Applications (24 papers), Immunotherapy and Immune Responses (8 papers), Medical Imaging and Pathology Studies (8 papers), Neuroendocrine Tumor Research Advances (6 papers), Lymphoma Diagnosis and Treatment (5 papers), Glycosylation and Glycoproteins Research (4 papers) and Medical Imaging Techniques and Applications (4 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (615 citations), Oncology (312 citations), Immunology and Allergy (41 citations), Pathology and Forensic Medicine (114 citations) and Immunology (113 citations). G.L. Buraggi has collaborated with scholars based in Italy, United States and Germany. Frequent co-authors include Emilio Bombardieri, L. Callegaro, Ettore Seregni, Giuliano Mariani, Flavio Crippa, Massimo Gasparini, M. Dovis, Marco Gasparini, N. Cascinelli and G Terno. Their work appears in journals such as The International Journal of Biological Markers, European Journal of Cancer, Cancer, Cancer treatment and research and International Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.